Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 G1 TherapeuticsDyne TherapeuticsFive Prime TherapeuticsAmphastar PharmaceuticalsADVANZ PHARMA
SymbolNASDAQ:GTHXNASDAQ:DYNNASDAQ:FPRXNASDAQ:AMPHOTCMKTS:CXRXF
Price Information
Current Price$24.70$17.16$37.99$17.40$16.81
52 Week RangeBuyBuyHoldHoldN/A
MarketRank™
Overall Score1.51.61.41.50.5
Analysis Score3.53.52.12.10.0
Community Score2.43.62.72.62.3
Dividend Score0.00.00.00.00.0
Ownership Score1.70.81.70.80.0
Earnings & Valuation Score0.00.00.61.90.0
Analyst Ratings
Consensus RecommendationBuyBuyHoldHoldN/A
Consensus Price Target$49.17$34.25$30.71$21.67N/A
% Upside from Price Target99.06% upside99.59% upside-19.15% downside24.52% upsideN/A
Trade Information
Market Cap$1.04 billion$883.02 million$1.77 billion$825.33 million$822.23 million
Beta2.44N/A4.40.87N/A
Average Volume1,534,940424,3571,995,277198,69415,458
Sales & Book Value
Annual RevenueN/AN/A$14.87 million$322.36 million$508.32 million
Price / SalesN/AN/A118.982.561.62
CashflowN/AN/AN/A$0.71 per shareN/A
Price / CashN/AN/AN/A24.42N/A
Book Value$6.80 per shareN/A$4.13 per share$9.11 per share$0.31 per share
Price / BookN/AN/A9.201.9154.23
Profitability
Net Income$-122,450,000.00N/A$-137,200,000.00$48.94 million$-196,020,000.00
EPS($3.27)N/A($3.92)$0.36N/A
Trailing P/E RatioN/A0.00N/A124.29N/A
Forward P/E RatioN/AN/AN/A15.68
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/A-554.71%1.97%-19.88%
Return on Equity (ROE)-49.35%N/A-75.84%5.50%N/A
Return on Assets (ROA)-41.53%N/A-49.08%4.04%-3.08%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.10%0.03%N/A0.07%N/A
Current Ratio7.45%81.20%5.35%2.86%1.75%
Quick Ratio7.45%81.20%5.35%1.73%1.24%
Ownership Information
Institutional Ownership Percentage77.89%59.43%67.28%55.08%N/A
Insider Ownership Percentage14.49%1.80%6.40%29.80%N/A
Miscellaneous
Employees12236871,980429
Shares Outstanding41.96 million51.46 million46.57 million47.43 million48.91 million
Next Earnings Date5/5/2021 (Estimated)6/3/2021 (Estimated)5/6/2021 (Estimated)5/6/2021 (Estimated)5/12/2021 (Estimated)
OptionableOptionableNot OptionableOptionableOptionableOptionable
SourceHeadline
Paladin Labs to commercialize Advanz Pharma’s Xydalba in CanadaPaladin Labs to commercialize Advanz Pharma’s Xydalba in Canada
pharmabiz.com - April 14 at 4:40 AM
ADVANZ PHARMA Corp. Limited (OTCMKTS:CXRXF) Short Interest Up 100.0% in MarchADVANZ PHARMA Corp. Limited (OTCMKTS:CXRXF) Short Interest Up 100.0% in March
americanbankingnews.com - March 29 at 5:42 PM
ADVANZ PHARMA (OTCMKTS:CXRXF) Shares Up 0.6%ADVANZ PHARMA (OTCMKTS:CXRXF) Shares Up 0.6%
americanbankingnews.com - March 25 at 12:30 AM
Advanz Pharma: Q4 Earnings SnapshotAdvanz Pharma: Q4 Earnings Snapshot
news.yahoo.com - March 17 at 11:02 PM
ADVANZ PHARMA Corp. Limited -- Moodys assigns B3 CFR to Cidron Aida Bidco Ltd (aka ADVANZ); outlook stableADVANZ PHARMA Corp. Limited -- Moody's assigns B3 CFR to Cidron Aida Bidco Ltd (aka ADVANZ); outlook stable
finance.yahoo.com - March 17 at 6:01 PM
ADVANZ PHARMA Corp. Limited Announces Fourth Quarter and 2020 ResultsADVANZ PHARMA Corp. Limited Announces Fourth Quarter and 2020 Results
finance.yahoo.com - March 17 at 8:01 AM
ADVANZ PHARMA Corp. Limited Announces Agreement Of Terms To Be Acquired By Nordic CapitalADVANZ PHARMA Corp. Limited Announces Agreement Of Terms To Be Acquired By Nordic Capital
prnewswire.com - January 27 at 4:33 AM
Guardant Health AMEA Wins Frost & Sullivans Market Leadership Award for Liquid Biopsy in Precision Oncology in Asia, Middle East and AfricaGuardant Health AMEA Wins Frost & Sullivan's Market Leadership Award for Liquid Biopsy in Precision Oncology in Asia, Middle East and Africa
finance.yahoo.com - December 14 at 11:17 PM
Advanz Pharma draws private equity interest as creditors want out -sourcesAdvanz Pharma draws private equity interest as creditors want out -sources
finance.yahoo.com - November 27 at 8:59 AM
Advanz Pharma: 3Q Earnings SnapshotAdvanz Pharma: 3Q Earnings Snapshot
sfgate.com - November 6 at 12:53 PM
ADVANZ PHARMA Corp. Limited Announces Third Quarter 2020 ResultsADVANZ PHARMA Corp. Limited Announces Third Quarter 2020 Results
finance.yahoo.com - November 6 at 7:53 AM
ADVANZ PHARMA Corp. Limited Announces Release Date for Third Quarter 2020 ResultsADVANZ PHARMA Corp. Limited Announces Release Date for Third Quarter 2020 Results
finance.yahoo.com - October 23 at 7:57 AM
Advanz Pharma Corp LtdAdvanz Pharma Corp Ltd
bloomberg.com - October 15 at 11:51 PM
IIROC Trading Halt - AIMD.PIIROC Trading Halt - AIMD.P
finance.yahoo.com - October 14 at 6:43 PM
Advanz Pharma Corp. Ltd.Advanz Pharma Corp. Ltd.
wsj.com - September 28 at 7:53 AM
Advanz Pharma: 2Q Earnings SnapshotAdvanz Pharma: 2Q Earnings Snapshot
sfgate.com - August 12 at 9:34 AM
ADVANZ PHARMA Corp. Limited Announces Second Quarter 2020 ResultsADVANZ PHARMA Corp. Limited Announces Second Quarter 2020 Results
finance.yahoo.com - August 12 at 9:34 AM
ADVANZ PHARMA Corp. Limited Announces Release Date for Second Quarter 2020 ResultsADVANZ PHARMA Corp. Limited Announces Release Date for Second Quarter 2020 Results
finance.yahoo.com - July 29 at 7:53 PM
ADVANZ PHARMA Corp. Limited Announces Results of Annual Meeting of ShareholdersADVANZ PHARMA Corp. Limited Announces Results of Annual Meeting of Shareholders
finance.yahoo.com - June 17 at 8:00 PM
Merger Arbitrage Mondays - 3 New Deals, 4 Completions And 1 Failed DealMerger Arbitrage Mondays - 3 New Deals, 4 Completions And 1 Failed Deal
seekingalpha.com - May 13 at 6:54 PM
CXRXF Advanz Pharma Corp Ltd - Ordinary Shares (Limited Voting)CXRXF Advanz Pharma Corp Ltd - Ordinary Shares (Limited Voting)
www.nasdaq.com - May 13 at 6:54 PM
ADVANZ PHARMA Corp. Limited Announces First Quarter 2020 ResultsADVANZ PHARMA Corp. Limited Announces First Quarter 2020 Results
finance.yahoo.com - May 13 at 8:53 AM
ADVANZ PHARMA Corp. Limited Completes Voluntarily Delisting from the Toronto Stock ExchangeADVANZ PHARMA Corp. Limited Completes Voluntarily Delisting from the Toronto Stock Exchange
finance.yahoo.com - March 27 at 6:54 PM
ADVANZ PHARMA Corp. Ltd. to Host Earnings CallADVANZ PHARMA Corp. Ltd. to Host Earnings Call
finance.yahoo.com - March 25 at 7:21 AM
ADVANZ PHARMA Corp. Limited Announces Fourth Quarter and 2019 ResultsADVANZ PHARMA Corp. Limited Announces Fourth Quarter and 2019 Results
finance.yahoo.com - March 25 at 7:21 AM
DateCompanyBrokerageAction
4/9/2021G1 TherapeuticsNeedham & Company LLCReiterated Rating
11/17/2020G1 TherapeuticsRaymond JamesDowngrade
10/5/2020G1 TherapeuticsHC WainwrightReiterated Rating
8/20/2020G1 TherapeuticsWedbushReiterated Rating
8/9/2020G1 TherapeuticsCowenReiterated Rating
6/26/2020G1 TherapeuticsRoth CapitalInitiated Coverage
5/12/2020G1 TherapeuticsJPMorgan Chase & Co.Lower Price Target
1/7/2020G1 TherapeuticsBTIG ResearchBoost Price Target
2/9/2021Dyne TherapeuticsJonestradingInitiated Coverage
10/12/2020Dyne TherapeuticsStifel NicolausInitiated Coverage
10/12/2020Dyne TherapeuticsPiper SandlerInitiated Coverage
10/12/2020Dyne TherapeuticsJefferies Financial GroupInitiated Coverage
3/15/2021Five Prime TherapeuticsGuggenheimReiterated Rating
3/4/2021Five Prime TherapeuticsWells Fargo & CompanyDowngrade
11/11/2020Five Prime TherapeuticsSVB LeerinkReiterated Rating
10/5/2020Amphastar PharmaceuticalsNorthland SecuritiesUpgrade
5/11/2020Amphastar PharmaceuticalsBMO Capital MarketsBoost Price Target
3/13/2019Amphastar PharmaceuticalsPiper Jaffray CompaniesDowngrade
3/15/2019ADVANZ PHARMABloom BurtonReiterated Rating
(Data available from 4/14/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.